Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRB · Real-Time Price · USD

Compare

19.12

-0.38 (-1.95%)

At close: Oct 10, 2025, 4:00 PM EDT

19.51

+0.39 (2.04%)

After-hours: Oct 10, 2025, 6:22 PM EDT

Seres Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2013 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2013 - 2019
Revenue	-	-	-	-	144.93	33.22	Upgrade
Revenue Growth (YoY)	-	-	-	-	336.33%	-3.74%	Upgrade
Gross Profit	-	-	-	-	144.93	33.22	Upgrade
Selling, General & Admin	-5.87	-	53.18	77.5	69.26	30.78	Upgrade
Research & Development	-10.54	-	64.6	117.6	141.89	90.57	Upgrade
Other Operating Expenses	-	-	3.53	-	-1.73	-	Upgrade
Total Operating Expenses	-16.41	0	121.32	195.1	209.42	121.35	Upgrade
Operating Income	16.41	-	-121.32	-195.1	-64.49	-88.13	Upgrade
Interest Income	-1.71	-	3.97	7.3	2.87	0.95	Upgrade
Interest Expense	-	-	-	-2.47	-2.91	-2.92	Upgrade
Other Non-Operating Income (Expense)	9.46	-	19.79	-0.13	-1.05	0.98	Upgrade
Total Non-Operating Income (Expense)	7.75	-	23.76	4.7	-1.09	-1	Upgrade
Pretax Income	24.16	-	-97.56	-190.4	-65.58	-89.13	Upgrade
Net Income	85.83	-	0.27	-227.45	-65.58	-89.13	Upgrade
Earnings From Discontinued Operations	13.9	-	125.91	76.41	-	-	Upgrade
Net Income to Common	85.83	-	0.27	-227.45	-65.58	-89.13	Upgrade
Shares Outstanding (Basic)	8	8	6	5	5	4	Upgrade
Shares Outstanding (Diluted)	8	8	6	5	5	4	Upgrade
Shares Change (YoY)	21.53%	21.40%	18.44%	17.86%	14.93%	40.85%	Upgrade
EPS (Basic)	11.32	-	-17.80	-46.20	-14.40	-22.40	Upgrade
EPS (Diluted)	11.31	-	-17.80	-46.20	-14.40	-22.40	Upgrade
Free Cash Flow	-60.38	-148.99	-125.33	-238.64	-2.88	-94.2	Upgrade
Free Cash Flow Per Share	-7.18	-19.17	-19.58	-44.16	-0.63	-23.61	Upgrade
Gross Margin	-	-	-	-	100.00%	100.00%	Upgrade
Operating Margin	-	-	-	-	-44.50%	-265.33%	Upgrade
Profit Margin	-	-	-	-	-45.25%	-268.33%	Upgrade
FCF Margin	-	-	-	-	-1.99%	-283.61%	Upgrade
EBITDA	21.03	5.47	-115.07	-188.47	-58.55	-81.55	Upgrade
EBITDA Margin	-	-	-	-	-40.40%	-245.53%	Upgrade
EBIT	16.41	-	-121.32	-195.1	-64.49	-88.13	Upgrade
EBIT Margin	-	-	-	-	-44.50%	-265.33%	Upgrade

Updated Aug 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q